190 related articles for article (PubMed ID: 29755843)
1. FDG PET-CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value.
Suárez-Piñera M; Belda-Sanchis J; Taus A; Sánchez-Font A; Mestre-Fusco A; Jiménez M; Pijuan L
Am J Nucl Med Mol Imaging; 2018; 8(2):100-109. PubMed ID: 29755843
[TBL] [Abstract][Full Text] [Related]
2. Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography.
Nakamura H; Saji H; Shinmyo T; Tagaya R; Kurimoto N; Koizumi H; Takagi M
Lung Cancer; 2015 Jan; 87(1):28-33. PubMed ID: 25481488
[TBL] [Abstract][Full Text] [Related]
3. Relationship between
Bu L; Tu N; Wang K; Zhou Y; Xie X; Han X; Lin H; Feng H
Korean J Radiol; 2022 Jan; 23(1):112-123. PubMed ID: 34983098
[TBL] [Abstract][Full Text] [Related]
4. 18F-fluorodeoxyglucose positron emission tomographic scan in solid-type p-stage-I pulmonary adenocarcinomas: what can produce false-negative results?
Lococo F; Galeone C; Formisano D; Bellafiore S; Filice A; Annunziata T; Cesario A; Rapicetta C; Fioroni F; Ricchetti T; Paci M
Eur J Cardiothorac Surg; 2017 Apr; 51(4):667-673. PubMed ID: 28043987
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.
Kadota K; Colovos C; Suzuki K; Rizk NP; Dunphy MP; Zabor EC; Sima CS; Yoshizawa A; Travis WD; Rusch VW; Adusumilli PS
Ann Surg Oncol; 2012 Oct; 19(11):3598-605. PubMed ID: 22644511
[TBL] [Abstract][Full Text] [Related]
7. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.
Yoshizawa A; Motoi N; Riely GJ; Sima CS; Gerald WL; Kris MG; Park BJ; Rusch VW; Travis WD
Mod Pathol; 2011 May; 24(5):653-64. PubMed ID: 21252858
[TBL] [Abstract][Full Text] [Related]
8. Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma.
Ercelep O; Alan O; Telli TA; Tuylu TB; Arıkan R; Demircan NC; Simsek ET; Babacan NA; Kaya S; Dane F; Bozkurtlar E; Ones T; Lacin T; Yumuk PF
Tumori; 2021 Jun; 107(3):231-237. PubMed ID: 32878562
[TBL] [Abstract][Full Text] [Related]
9. Predictive accuracy of lepidic growth subtypes in early-stage adenocarcinoma of the lung by quantitative CT histogram and FDG-PET.
Eriguchi D; Shimada Y; Imai K; Furumoto H; Okano T; Masuno R; Matsubayashi J; Kajiwara N; Ohira T; Ikeda N
Lung Cancer; 2018 Nov; 125():14-21. PubMed ID: 30429012
[TBL] [Abstract][Full Text] [Related]
10. Histopathology of lung adenocarcinoma based on new IASLC/ATS/ERS classification: prognostic stratification with functional and metabolic imaging biomarkers.
Lee HY; Jeong JY; Lee KS; Yi CA; Kim BT; Kang H; Kwon OJ; Shim YM; Han J
J Magn Reson Imaging; 2013 Oct; 38(4):905-13. PubMed ID: 23908132
[TBL] [Abstract][Full Text] [Related]
11. Role of PET/CT in Management of Early Lung Adenocarcinoma.
Shao X; Niu R; Jiang Z; Shao X; Wang Y
AJR Am J Roentgenol; 2020 Feb; 214(2):437-445. PubMed ID: 31714848
[No Abstract] [Full Text] [Related]
12. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H
J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438
[TBL] [Abstract][Full Text] [Related]
13. Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.
Behera M; Owonikoko TK; Gal AA; Steuer CE; Kim S; Pillai RN; Khuri FR; Ramalingam SS; Sica GL
Clin Lung Cancer; 2016 Sep; 17(5):e57-e64. PubMed ID: 27137345
[TBL] [Abstract][Full Text] [Related]
14. The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations.
Tsuta K; Kawago M; Inoue E; Yoshida A; Takahashi F; Sakurai H; Watanabe SI; Takeuchi M; Furuta K; Asamura H; Tsuda H
Lung Cancer; 2013 Sep; 81(3):371-376. PubMed ID: 23891509
[TBL] [Abstract][Full Text] [Related]
15. Comparison of outcomes for patients with lepidic pulmonary adenocarcinoma defined by 2 staging systems: A North American experience.
Wilshire CL; Louie BE; Horton MP; Castiglioni M; Aye RW; Farivar AS; West HL; Gorden JA; Vallières E
J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1561-8. PubMed ID: 26897242
[TBL] [Abstract][Full Text] [Related]
16. The Role of Histogram-Based Textural Analysis of
Önner H; Coşkun N; Erol M; Eren Karanis Mİ
Mol Imaging Radionucl Ther; 2022 Feb; 31(1):33-41. PubMed ID: 35114750
[TBL] [Abstract][Full Text] [Related]
17. Use of a prognostic risk score that aggregates the FDG-PET/CT SUVmax, tumor size, and histologic group for predicting the prognosis of pStage I lung adenocarcinoma.
Kawakita N; Toba H; Kawakami Y; Takizawa H; Bando Y; Otuska H; Matsumoto D; Takashima M; Tsuboi M; Yoshida M; Kondo K; Tangoku A
Int J Clin Oncol; 2020 Jun; 25(6):1079-1089. PubMed ID: 32130543
[TBL] [Abstract][Full Text] [Related]
18. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.
Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786
[TBL] [Abstract][Full Text] [Related]
19. Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?
Ito H; Nakayama H; Murakami S; Yokose T; Katayama K; Miyata Y; Okada M
Gen Thorac Cardiovasc Surg; 2017 Sep; 65(9):512-518. PubMed ID: 28593420
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of
Lococo F; Guerrera F; Rena O; Ampollini L; Vannucci J; Bertoglio P; Ventura L; Lyberis P; Marchese V; Arena V; Filosso PL; Lesca A; Casadio C; Viti A; Paci M; Puma F; Ruffini E
Heart Lung Circ; 2022 May; 31(5):726-732. PubMed ID: 34753661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
